109 related articles for article (PubMed ID: 1620204)
1. Discussion: statistical analysis in treatment and prevention program evaluation.
Ager JW
NIDA Res Monogr; 1992; 117():31-40. PubMed ID: 1620204
[No Abstract] [Full Text] [Related]
2. Discussion: effect of legal stipulations on the conduct of treatment and prevention research.
Howard J
NIDA Res Monogr; 1992; 117():385-93. PubMed ID: 1620209
[No Abstract] [Full Text] [Related]
3. Methodological issues in prevention research on drug use and pregnancy.
Gilchrist LD; Gillmore MR
NIDA Res Monogr; 1992; 117():1-17. PubMed ID: 1620189
[No Abstract] [Full Text] [Related]
4. Measurement issues in the evaluation of experimental treatment interventions.
McLellan AT
NIDA Res Monogr; 1992; 117():18-30. PubMed ID: 1620195
[TBL] [Abstract][Full Text] [Related]
5. Discussion: dilemmas in research in perinatal addiction--intervention issues.
Finnegan LP
NIDA Res Monogr; 1992; 117():344-8. PubMed ID: 1620206
[No Abstract] [Full Text] [Related]
6. The use of support groups among pregnant substance abusers: implications for managed care.
Fox MH; McCaul ME; Stuart ME; Svikis DS; Kerns A
Best Pract Benchmarking Healthc; 1996; 1(2):89-93. PubMed ID: 9192581
[TBL] [Abstract][Full Text] [Related]
7. Drug and alcohol use during pregnancy: we need to protect, not punish, women.
Armstrong EM
Womens Health Issues; 2005; 15(2):45-7. PubMed ID: 15767193
[No Abstract] [Full Text] [Related]
8. Discussion: measurement issues in the study of effects of substance abuse in pregnancy.
Coles CD
NIDA Res Monogr; 1992; 117():248-58. PubMed ID: 1620200
[No Abstract] [Full Text] [Related]
9. Drug addiction in pregnancy and pregnancy outcome: a call for global solutions.
Kuczkowski KM
Subst Use Misuse; 2005; 40(11):1749-50. PubMed ID: 16253939
[No Abstract] [Full Text] [Related]
10. Drug-exposed infants. American Academy of Pediatrics Committee on Substance Abuse.
Pediatrics; 1995 Aug; 96(2 Pt 1):364-7. PubMed ID: 7630703
[No Abstract] [Full Text] [Related]
11. Testing for maternal drug abuse: how much is enough?
Maynard EC
Pediatrics; 1991 May; 87(5):742. PubMed ID: 2020527
[No Abstract] [Full Text] [Related]
12. A treatment evaluation agenda: discussion and recommendations.
Tims FM; Holland S
NIDA Res Monogr; 1984; 51():167-74. PubMed ID: 6438516
[No Abstract] [Full Text] [Related]
13. [Detection is not prevention].
Segura Benedicto A
Med Clin (Barc); 1995 Jun; 105(2):78. PubMed ID: 7603103
[No Abstract] [Full Text] [Related]
14. Planning for future actions. Workshop on education and outreach initiatives.
O'Hare D
Bull N Y Acad Med; 1991; 67(3):304-7. PubMed ID: 1868282
[No Abstract] [Full Text] [Related]
15. Stem the human, financial toll of drug abuse in pregnancy.
Dis Manag Advis; 2000 Nov; 6(11):165-8. PubMed ID: 11188286
[No Abstract] [Full Text] [Related]
16. Building bridges: treatment research partnerships in the community.
Chasnoff IJ; Marques PR; Strantz IH; Farrow J; Davis S
NIDA Res Monogr; 1996; 166():6-21. PubMed ID: 8818162
[No Abstract] [Full Text] [Related]
17. Introduction to the Perinatal-20 treatment research demonstration program.
Rahdert ER
NIDA Res Monogr; 1996; 166():1-5. PubMed ID: 8818161
[No Abstract] [Full Text] [Related]
18. The right to quality life: a challenge for parenting education.
Gaines J
Health Educ; 1981; 12(2):18-20. PubMed ID: 6790460
[No Abstract] [Full Text] [Related]
19. Safe havens for addicted mothers.
Chudley AE
CMAJ; 1997 Nov; 157(9):1201; author reply 1202. PubMed ID: 9361635
[No Abstract] [Full Text] [Related]
20. [Perinatal consequences of substance abuse during pregnancy].
Lejeune C
Arch Pediatr; 2007 Jun; 14(6):656-8. PubMed ID: 17419031
[No Abstract] [Full Text] [Related]
[Next] [New Search]
